GlassScriptPhysician profile
Michael J Cipolla
NPI 1841450137
$7,308.57
in general payments reported to CMS, 2019-2025
20 companies · $1,028 in 2025
The $1,028 reported for 2025 was more than what 80% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $694 · 2020: $399 · 2021: $666 · 2022: $1,038 · 2023: $1,997 · 2024: $1,487 · 2025: $1,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,681 · Travel and Lodging: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,681.07 |
| Travel and Lodging | $830.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $844.83 | 2019-2025 | Halo, Tula, Coblation |
| Aerin Medical INC. | $843.36 | 2019-2025 | |
| Medical Device Business Services, INC. | $830.91 | 2023 | |
| Medtronic, INC. | $813.59 | 2021-2025 | Propel, Pteye Parathyroid Detection System, Sinuva |
| Intersect Ent, INC. | $798.92 | 2019-2022 | |
| Acclarent, INC | $685.46 | 2020-2023 | Trudi Nav Cable, Relieva Tract |
| Stryker Corporation | $469.62 | 2019-2025 | Audion Et Dilation System |
| Integra Lifesciences Corporation | $419.53 | 2021-2024 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Optinose US, INC. | $332.12 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $306.38 | 2019-2025 | Dupixent |
| Cochlear Americas | $217.11 | 2022-2024 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Glaxosmithkline, LLC. | $211.22 | 2023-2025 | Nucala |
| Genzyme Corporation | $194.16 | 2024-2025 | |
| Abbvie INC. | $131.01 | 2024 | |
| Alk-Abello, INC | $64.29 | 2020-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurent Medical Limited | $59.98 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Merck Sharp & Dohme LLC | $38.18 | 2023-2025 | Bridion |
| Phathom Pharmaceuticals, INC. | $20.13 | 2024 | Voquezna |
| Amgen INC. | $14.42 | 2025 | Tezspire |
| Karl Storz Endoscopy-America | $13.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cipolla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.